Keywords
How to Cite
Abstract
This article reviews current understanding of topical corticosteroid withdrawal syndrome (TCWS) in atopic dermatitis. It highlights the rising prevalence of atopic dermatitis among both children and adults, as well as the impact of urbanization and environmental factors on its incidence. Particular attention is paid to the development of dependence on topical steroids, the “vicious cycle” mechanism, and the phenomenon of tachyphylaxis. The clinical differences between TSW and exacerbations of atopic dermatitis are analyzed, which is important for diagnosis and the selection of treatment strategies.
References
1. Ab Hadi H. (и др.) The Epidemiology and Global Burden of Atopic Dermatitis: A Narrative Review // Journal of the American Academy of Dermatology International. – 2021. – Vol. 1, № 1. – P. 55–64.
2. Arnold K. A., Treister A. D., Lio P. A. Dupilumab in the management of topical corticosteroid withdrawal in atopic dermatitis: A retrospective case series // JAAD Case Reports. – 2018. – Vol. 4, № 9. – P. 860–862.
3. Brookes T. S., Barlow R., Mohandas P., Bewley A. Topical steroid withdrawal: an emerging clinical problem // Clinical and Experimental Dermatology. – 2023. – Vol. 48, № 9. – P. 1007–1011.
4. Chu D. K., Schneider L., Asiniwasis R. N. et al. Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE- and Institute of Medicine-based recommendations // Annals of Allergy, Asthma & Immunology. – 2024. – Vol. 132, № 3. – P. 274–312.
5. Del Rosso J. Q. Topical corticosteroid application and the structural and functional integrity of the epidermal barrier // Journal of Clinical and Aesthetic Dermatology. – 2013. – Vol. 6, № 11. – P. 24–32.